Cooper Companies is a global medical device company that specializes in the design, manufacture, and marketing of innovative products in the eye care and women's health sectors
The company is best known for its extensive range of contact lenses, which cater to various needs including vision correction and lifestyle enhancements. Additionally, Cooper Companies offers a suite of women’s health products, particularly in the areas of fertility and other reproductive health solutions, aiming to improve the quality of life for individuals worldwide. Through its commitment to research and development, the company seeks to advance technology and provide high-quality, effective solutions for its customers.
SAN RAMON, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report first quarter 2025 financial results on Thursday, March 6, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc., The Procter & Gamble Co., and Sony Group Corp., as well as a micro-cap stock The Monarch Cement Co..
SAN RAMON, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, today announced it will participate at the J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025. Al White, President and CEO, will represent the Company in a session scheduled to begin at 6:00 PM ET.
SAN RAMON, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal fourth quarter and full year ended October 31, 2024.
SAN RAMON, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report fourth quarter and full year 2024 financial results on Thursday, December 5, 2024, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
CooperSurgical, a global leader in women’s healthcare, today announced the launch of a new inserter designed for single-hand placement of Paragard®, which was recently approved by the U.S. Food and Drug Administration (FDA). The new single-hand inserter simplifies the placement process for healthcare providers, making Paragard an even more accessible contraceptive choice for both providers and patients. Paragard, the #1 prescribed copper intrauterine device (IUD), is a tried and true, non-hormonal contraceptive option with more than 30 years of clinical use.
Able to exceed top and bottom line expectations on Wednesday, here are three of these intriguing companies to invest in as their stocks continue to outperform the broader market.
After dilly-dallying in recent sessions amid anticipation ahead of Nvidia Corp.’s (NASDAQNVDA) earnings, market mood is settling in. The index futures were higher in early trading.
SAN RAMON, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2024.
SAN RAMON, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced its participation in the following upcoming investor conferences:
